State-of-the-Art in Antimicrobial Research in Greece

Dear Colleagues,

Greece has been among the European countries with the highest consumption of antibacterials in terms of DDDs (defined daily doses) per 1000 inhabitants per day for several years, according to data reported by the ECDC and OECD.

Another concern regarding antimicrobials in Greece is the use of antibacterials in the community: although in hospitals there is strict stewardship of antibacterial use, in the community there is uncontrolled overuse and misuse of antibacterials, exacerbated by over-the-counter use of antimicrobials. Indeed, until recently, antibacterials could be bought without a prescription in Greece.

Consequently, the overuse and misuse of antibiotics have increased antibiotic resistance, especially in hospital isolates.

To address the serious problem of antimicrobial resistance, it is obvious that strategic research and combined action should be performed in three main areas: basic research for the development of new and innovative antimicrobial agents, antimicrobial resistance surveillance and containment, and stewardship of antimicrobial use.

The aim of this Special Issue is to publish state-of-the-art antimicrobial research in Greece, including basic scientific research, epidemiological data and research from bench to clinical practice, as well as the pharmacoepidemiology and management of antimicrobial use. We invite contributions of research on all kinds of antimicrobials and all aspects of relevant research. The concept of the One Health approach is also welcome.

Dr. Paraskevi Papaioannidou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.